Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Anemia
NCT ID: NCT01011361
Last Updated: 2016-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5 participants
OBSERVATIONAL
2009-04-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anemia in the Elderly
NCT00640172
Etiology of Anemia
NCT00302939
Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women
NCT02683369
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967
Clinical Signs and Symptoms of Anemia in Patients Over 75 Years
NCT02662699
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anemia (hemoglobin \< 13 g/dL in men or \< 12 g/dL in women)
* Outpatient at either the Stanford Health Care (SHC) Medical Center or VA Palo Alto Health Care System
Exclusion Criteria
* \< 18.5 kg/m2
* \> 35 kg/m2
* Palpable splenomegaly
* Contraindication to RBC mass/plasma volume testing
* On any experimental pharmacologic agent in the prior 2 months
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stanley L Schrier
Professor of Medicine (Hematology), Emeritus
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stanley L Schrier, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-07302009-3480
Identifier Type: OTHER
Identifier Source: secondary_id
IRB-16209
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.